Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  AngioDynamics, Inc.    ANGO

ANGIODYNAMICS, INC.

(ANGO)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/27/2020 11/30/2020 12/01/2020 12/02/2020 12/03/2020 Date
14.36(c) 14.22(c) 13.85(c) 13.88(c) 14.14 Last
167 694 224 635 341 674 306 363 365 269 Volume
-0.14% -0.97% -2.60% +0.22% +1.87% Change
More quotes
Financials (USD)
Sales 2021 282 M - -
Net income 2021 -16,5 M - -
Net Debt 2021 - - -
P/E ratio 2021 -32,9x
Yield 2021 -
Sales 2022 297 M - -
Net income 2022 -9,48 M - -
Net Debt 2022 - - -
P/E ratio 2022 -58,1x
Yield 2022 -
Capitalization 537 M 537 M -
Capi. / Sales 2021 1,91x
Capi. / Sales 2022 1,81x
Nbr of Employees 800
Free-Float 95,9%
More Financials
Company
AngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company's devices are used in minimally invasive, image-guided procedures. The Company offers products within three product groupings: Vascular... 
More about the company
Notations Surperformance© of AngioDynamics, Inc.
Trading Rating : Investor Rating :
More Ratings
All news about ANGIODYNAMICS, INC.
11/19ANGIODYNAMICS : Latest Federal Court Cases, 11/16/20
AQ
11/19ANGIODYNAMICS INC : Regulation FD Disclosure, Financial Statements and Exhibits ..
AQ
11/13ANGIODYNAMICS : Claims To Printed Matter Are Patent-Ineligible Only If They Lack..
AQ
11/12ANGIODYNAMICS : Announces Presentation of Positive Safety, Efficacy Results from..
BU
10/26ANGIODYNAMICS : rsquo; Fiscal 2021 First Quarter Financial Results
PU
10/15ANGIODYNAMICS INC : Change in Directors or Principal Officers, Submission of Mat..
AQ
10/07ANGIODYNAMICS : Management's Discussion and Analysis of Financial Condition and ..
AQ
09/29ANGIODYNAMICS : Fiscal 1Q Earnings Snapshot
AQ
09/29ANGIODYNAMICS INC : Results of Operations and Financial Condition, Regulation FD..
AQ
09/29ANGIODYNAMICS : Reports Fiscal 2021 First Quarter Financial Results
BU
09/21ANGIODYNAMICS : Announces Commercial Launch of Auryon Atherectomy System in Unit..
BU
09/17ANGIODYNAMICS : to Report Fiscal 2021 First Quarter Financial Results on Septemb..
BU
08/17ANGIODYNAMICS : Announces First Patient Enrolled in PATHFINDER I Registry Examin..
BU
08/14ANGIODYNAMICS INC : Change in Directors or Principal Officers (form 8-K)
AQ
08/10ANGIODYNAMICS : Management's Discussion and Analysis of Financial Conditions and..
AQ
More news
News in other languages on ANGIODYNAMICS, INC.
04/02ANGIODYNAMICS, INC. : Veröffentlichung des Quartalsergebnisses
04/02ANGIODYNAMICS, INC. : publication des résultats trimestriels
2019ANGIODYNAMICS, INC. : Veröffentlichung des Quartalsergebnisses
2019ANGIODYNAMICS, INC. : publication des résultats trimestriels
2019ANGIODYNAMICS, INC. : Veröffentlichung des Halbjahresergebnisses
More news
Chart ANGIODYNAMICS, INC.
Duration : Period :
AngioDynamics, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ANGIODYNAMICS, INC.
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 16,00 $
Last Close Price 14,14 $
Spread / Highest target 27,3%
Spread / Average Target 13,2%
Spread / Lowest Target -0,99%
EPS Revisions
Managers
NameTitle
James Christopher Clemmer President, Chief Executive Officer & Director
Howard W. Donnelly Chairman
David D. Helsel Senior Vice President-Global Operations, R&D
Stephen A. Trowbridge Chief Financial Officer, EVP & General Counsel
Kim L. Seabury Senior Vice President-Information Technology
Sector and Competitors
1st jan.Capitalization (M$)
ANGIODYNAMICS, INC.-13.30%527
COLOPLAST A/S10.14%31 435
TELEFLEX INCORPORATED1.05%17 713
TOP GLOVE CORPORATION BHD.332.77%13 154
HARTALEGA HOLDINGS167.52%12 129
SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED57.17%8 494